CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Research methodology
1.2.1.Secondary research
1.2.2.Primary research
1.2.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Overview
3.2.Porters five Analysis
3.3.Drivers
3.3.1.Technological advancements in anesthesia monitoring
3.3.2.Rise in number of surgical procedures
3.4.Restraints
3.4.1.High cost of installation and maintenance
3.4.2.Regulatory compliances
3.5.Opportunities
3.5.1.Rise in demand for quality healthcare monitoring
3.5.2.Untapped opportunities in emerging economies
CHAPTER 4:GLOBAL ANESTHESIA MACHINE MARKET, BY TYPE
4.1.Overview
4.2.Continuous anesthesia machine
4.2.1.Key market trends and opportunities
4.2.2.Market forecast by region, 2018-2026
4.3.Intermittent anesthesia machine
4.3.1.Key trends and opportunities
4.3.2.Market Forecast, by region, 2018-2026
CHAPTER 5:ANESTHESIA MACHINE MARKET, BY SUBJECT
5.1.Overview
5.2.Human
5.2.1.Market Forecast, by region, 2018-2026
5.3.Veterinary
5.3.1.Market Forecast, by region, 2018-2026
CHAPTER 6:ANESTHESIA MACHINE MARKET, BY APPLICATION
6.1.Overview
6.2.Nervous system surgeries
6.2.1.Market Forecast, by region, 2018-2026
6.3.Respiratory system surgeries
6.3.1.Market Forecast, by region, 2018-2026
6.4.Cardiovascular system surgeries
6.4.1.Market Forecast, by region, 2018-2026
6.5.Digestive system surgeries
6.5.1.Market Forecast, by region, 2018-2026
6.6.Urinary system surgeries
6.6.1.Market Forecast, by region, 2018-2026
6.7.ENT system surgeries
6.7.1.Market Forecast, by region, 2018-2026
6.8.Musculoskeletal system surgeries
6.8.1.Market Forecast, by region, 2018-2026
6.9.Others
6.9.1.Market Forecast, by region, 2018-2026
CHAPTER 7:ANESTHESIA MACHINE MARKET, BY END USER
7.1.Overview
7.2.Hospitals
7.2.1.Market Forecast, by region, 2018-2026
7.3.Point of care
7.3.1.Market Forecast, by region, 2018-2026
7.4.Others
7.4.1.Market Forecast, by region, 2018-2026
CHAPTER 8:ANESTHESIA MACHINE MARKET, BY REGION
8.1.Overview
8.2.North America
8.2.1.U.S.
8.2.1.1.Market Forecast, 2018-2026
8.2.2.Canada
8.2.2.1.Market Forecast, 2018-2026
8.2.3.Mexico
8.2.3.1.Market Forecast, 2018-2026
8.3.Europe
8.3.1.Germany
8.3.1.1.Market Forecast, 2018-2026
8.3.2.France
8.3.2.1.Market Forecast, 2018-2026
8.3.3.UK
8.3.3.1.Market Forecast, 2018-2026
8.3.4.Italy
8.3.4.1.Market Forecast, 2018-2026
8.3.5.Spain
8.3.5.1.Market Forecast, 2018-2026
8.3.6.Rest of Europe
8.3.6.1.Market Forecast, 2018-2026
8.4.Asia-Pacific
8.4.1.Japan
8.4.1.1.Market Forecast, 2018-2026
8.4.2.China
8.4.2.1.Market Forecast, 2018-2026
8.4.3.India
8.4.3.1.Market Forecast, 2018-2026
8.4.4.Australia
8.4.4.1.Market Forecast, 2018-2026
8.4.5.Rest of Asia-Pacific
8.4.5.1.Market Forecast, 2018-2026
8.5.LAMEA
8.5.1.Brazil
8.5.1.1.Market Forecast, 2018-2026
8.5.2.Saudi Arabia
8.5.2.1.Market Forecast, 2018-2026
8.5.3.South Africa
8.5.3.1.Market Forecast, 2018-2026
8.5.4.Rest of LAMEA
8.5.4.1.Market Forecast, 2018-2026
CHAPTER 9:ANESTHESIA MACHINE MARKET, BY COMPANY PROFILE
9.1.CARDINAL HEALTH INC.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.DRaGERWERK AG & CO. KGAA
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Product portfolio
9.2.4.Business performance
9.3.FISHER & PAYKEL HEALTHCARE LIMITED
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.4.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.5.HEYER MEDICAL AG
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.6.KONINKLIJKE PHILIPS N.V.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product type Portfolio
9.6.5.Business performance
9.7.MINDRAY DS USA INC
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Key strategic moves and developments
9.8.SMITHS GROUP PLC.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.TELEFLEX INCORPORATED
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.10.VYAIRE MEDICAL INC
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
